文献速递肾癌与肾肿瘤

高危非转移性肾细胞癌根治性肾切除术中淋巴结清扫与生存的关联:多机构分析

Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis.
PubMed 文献 · J Urol · 2017-12-07

该多机构分析纳入1990至2010年两家国际中心2722例M0肾细胞癌根治性肾切除术患者,评估淋巴结清扫与远处转移、癌特异性及全因死亡的关系。中位随访9.6年,171例(6.3%)为pN1。倾向评分调整后,淋巴结清扫在总体队列、cN1患者及pN1概率递增亚组中均与远处转移风险、癌特异性或全因死亡无显著关联。

要点

  • 总体队列中淋巴结清扫与远处转移、癌特异性死亡及全因死亡风险无显著关联。
  • cN1患者及pN1概率从≥0.10至≥0.50递增的亚组中,淋巴结清扫均无显著生存获益。
  • 扩大淋巴结清扫或清扫范围均与肿瘤学结局改善无关。

核心结论

  • 在高危M0肾细胞癌根治性肾切除术患者中,淋巴结清扫与肿瘤学结局改善无关,包括cN1患者及pN1概率递增阈值人群。

研究设计与样本

  • 多机构分析纳入1990至2010年两家国际中心2722例M0肾细胞癌根治性肾切除术患者,采用倾向评分技术和传统多变量Cox回归评估淋巴结清扫与结局的关联。

主要发现

  • 总体171例(6.3%)为pN1,中位随访9.6年,倾向评分调整后临床病理特征均衡。
  • 总体队列中淋巴结清扫与远处转移风险、癌特异性死亡或全因死亡无显著关联。
  • cN1患者及pN1概率从≥0.10至≥0.50递增的亚组中,淋巴结清扫与结局无显著关联。
  • 扩大淋巴结清扫或淋巴结清扫范围均与肿瘤学结局改善无关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Lymph node dissection may benefit patients at increased risk for lymph node metastases from renal cell carcinoma. Therefore, we evaluated the association of lymph node dissection with survival in patients at high risk undergoing radical nephrectomy for renal cell carcinoma. MATERIALS AND METHODS: We identified 2,722 patients with M0 renal cell carcinoma who underwent radical nephrectomy with or without lymph node dissection at 2 international centers from 1990 to 2010. The associations of lymph node dissection with the development of distant metastases, and cancer specific and all cause mortality were evaluated using propensity score techniques and traditional multivariable Cox regression. Subset analyses were done to examine patients at increased risk of lymph node metastases. RESULTS: Overall 171 patients (6.3%) had pN1 disease. Median followup was 9.6 years. Clinicopathological features were well balanced after propensity score adjustment. Lymph node dissection was not significantly associated with a reduced risk of distant metastases, or cancer specific or all cause mortality in the overall cohort, among patients with preoperative radiographic lymphadenopathy (cN1), or across an increasing probability of pN1 disease from 0.10 or greater to 0.50 or greater. Neither extended lymph node dissection nor the extent of lymph node dissection was associated with improved oncologic outcomes. CONCLUSIONS: The current analysis of a large, international cohort indicates that lymph node dissection is not associated with improved oncologic outcomes among patients at high risk who undergo radical nephrectomy for M0 renal cell carcinoma. This includes patients with radiographic lymphadenopathy (cN1) and across increasing probability thresholds of pN1 disease.

来源:J Urol,查看原文。版权归原作者所有。

引用

  1. Gershman B, Thompson RH, Boorjian SA, et al. Radical Nephrectomy with or without Lymph Node Dissection for High Risk Nonmetastatic Renal Cell Carcinoma: A Multi-Institutional Analysis. J Urol. 2017. PMID: 29225056. doi:10.1016/j.juro.2017.11.114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。